Kidney Res Clin Pract > Volume 38(2); 2019 > Article
Clark: Is high fluid intake good for the kidney?
The article by Min et al [1], in the current issue of Kidney Research and Clinical Practice discusses the role of sub-morbid dehydration in initiating glomerular hyper-filtration as a potential harbinger and cause of progressive chronic kidney injury. They conducted a cross-sectional analysis of over 28,342 ambulatory, community-dwelling, civilian, non-institutionalized Korean adults as part of the Korea National Health and Nutrition Examination Surveys, which measure urine specific gravity (SGU) as the primary variable indicating hydration status. The estimated glomerular filtration rate (eGFR) was considered as the primary outcome. In their study, sub-morbid dehydration measured by increased SGU was associated with higher eGFR, and they concluded that the clinical significance of sub-morbid dehydration-associated glo-merular hyperfiltration requires further investigation.
Though the initial interpretation of their observational study was plausible, critical evaluation of these results is still necessary. SGU is a crude measure of the kidney’s ability to concentrate urine, relying both on kidney function and the state of hydration. The subjects’ SGU and eGFR values were estimated after 8 hours of fasting. The confounder between eGFR and specific gravity is that those with higher eGFRs (i.e., better kidney function) would be expected to concentrate their urine to a higher specific gravity after 8 hours of fasting. This interpretation is consistent with the fact that the quartile with the highest specific gravity consists of those who are significantly younger, as noted in Table 1 of their study; in particular, age is associated with progressive decline in kidney function [2]. Additionally, they noted higher eGFR is negatively associated with diabetes mellitus and proteinuria, which agrees with the well-known associated risk of lower eGFR due to decreased kidney function, as noted in Table 2 of their study [2]. However, in defense of their hypothesis, they note a highly significant correlation between eGFR and SGU after multivariate adjustment in their study, which is one of the largest observational studies of postulated sub-morbid dehydration associated hyperfiltration. Dehydration is known to induce vasopressin release. There is ample human and animal experimental evidence supporting a causative role of vasopressin in renal hyperfiltration induction and the development of proteinuria with associated progressive renal injury [3]. However, the coining of the term “sub-morbid dehydration associated glomerular hyperfiltration” adds a subtle new wrinkle to the dialogue regarding hydration and its potential role in the pathogenesis of kidney disease.
While the cross-sectional nature of their study precludes causal associations, longitudinal studies of their patient cohort may yield stronger associations, particularly if copeptin (a vasopressin analogue) measurements are performed to understand vasopressin’s relationship with sub-morbid dehydration [4,5]. We note that in a population of 2,148 community dwelling adults with eGFR > 60 mL/min/1.73 m2, a 6-year longitudinal follow-up study demonstrated that declined kidney function was significantly slower in those with higher versus lower urine volume, demonstrating a dose response effect [6] (Fig. 1). In other words, people with normal kidney function and increased hydration (i.e., increased urine output) had better preservation of eGFR over 6 years relative to those with lower urine output and presumed suboptimal hydration (Fig. 2). These findings and the work of several others have prompted us to conduct a randomized control trial of the effect of increasing water intake on kidney function decline in 631 adults with chronic kidney disease [7]. In this study, no association was detected after 1 year. We looked at all water drinkers (average intake, 2.6 L/day) with only mildly elevated copeptin, and attempts to increase their average intake by 1.5 L of water failed (with their actual average increase being 0.6 L), even with active coaching; this result is in contrast to studies on low water intake [8,9]. It may be short-sighted to look at all chronic kidney disease patients rather than those who are low-water drinkers (i.e., those with low water intake) or individuals suffering from sub-morbid dehydration, who are at greater risk of progressive loss of kidney function, as evidenced by our original longitudinal observations of normal subjects with decreased urine output [6].
The current article on the role of sub-morbid dehydration induced hyperfiltration warrants further investigation to determine its significance over time regarding the pathophysiology of kidney injury. The potential action of sub-morbid dehydration induced renal hyperfiltration becomes more important when considering the rising awareness of heat-stress dehydration and subsequent renal injury in this era of global warming [10]. Thus, sub-morbid dehydration may be an emerging reality that needs serious consideration.

Notes

Conflicts of interest

The author’s last completed randomized controlled trial was funded by Danone Research.

Figure 1

Decline in kidney function between the first and last assessments over 5.7 years (n = 2,148)

Reproduced from the article of Clark et al [6] with original copyright holder’s permission. eGFR, estimated glomerular filtration rate.
krcp-38-135f1.jpg
Figure 2

Urine volume and risk for renal decline in the general population (n = 2,148)

Reproduced from the article of Clark et al [6] with original copyright holder’s permission.
OR, odds ratio; CI, confidence interval.
aMultinomial logistic regression adjusted for age, sex, baseline estimated glomerular filtration rate (eGFR), dipstick protein ≥ 1 g/L, medication use for hypertension (including diuretics), diabetes and cardiovascular disease.
beGFR decline from baseline between 1% and 4.9%, ceGFR decline from baseline ≥ 5%.
krcp-38-135f2.jpg

References

1. Min HK, Sung SA, Lee SY, Lee SW. Sub-morbid dehydration-associated glomerular hyperfiltration: An emerging reality? Kidney Res Clin Pract 2019;38:196–204.
crossref pmid pmc
2. Clark WF, Macnab JJ, Chen SJ, Suri R, Moist L, Garg AX. Evaluation of GFR estimating equations in the general community: implications for screening. Clin J Am Soc Nephrol 2006;1:787–795.
crossref pmid
3. Clark WF, Sontrop JM, Huang SH, Moist L, Bouby N, Bankir L. Hydration and chronic kidney disease progression: a critical review of the evidence. Am J Nephrol 2016;43:281–292.
crossref pmid
4. Clark WF, Devuyst O, Roussel R. The vasopressin system: new insights for patients with kidney diseases: epidemiological evidence and therapeutic perspectives. J Intern Med 2017;282:310–321.
crossref pmid
5. Guelinckx I, Vecchio M, Perrier ET, Lemetais G. Fluid intake and vasopressin: connecting the dots. Ann Nutr Metab 2016;68(Suppl 2):6–11.
crossref pmid
6. Clark WF, Sontrop JM, Macnab JJ, et al. Urine volume and change in estimated GFR in a community-based cohort study. Clin J Am Soc Nephrol 2011;6:2634–2641.
crossref pmid pmc
7. Clark WF, Sontrop JM, Huang SH, et al. Effect of coaching to increase water intake on kidney function decline in adults with chronic kidney disease: The CKD WIT randomized clinical trial. JAMA 2018;319:1870–1879.
crossref pmid pmc
8. Hooton TM, Vecchio M, Iroz A, et al. Effect of increased daily water intake in premenopausal women with recurrent urinary tract infections: a randomized clinical trial. JAMA Intern Med 2018;178:1509–1515.
crossref pmid pmc
9. Enhörning S, Brunkwall L, Tasevska I, et al. Water supplementation reduces copeptin and plasma glucose in adults with high copeptin: The H2O Metabolism Pilot Study. J Clin Endocrinol Metab 2019;104:1917–1925.
crossref pmid
10. Johnson RJ, Stenvinkel P, Jensen T, et al. Metabolic and kidney diseases in the setting of climate change, water shortage, and survival factors. J Am Soc Nephrol 2016;27:2247–2256.
crossref pmid pmc
TOOLS
METRICS Graph View
  • 1 Web of Science
  • 2 Crossref
  • 1 Scopus
  • 2,177 View
  • 25 Download
Related articles

Is immunosenesence good for kidney injury?2019 March;38(1)



ABOUT
BROWSE ARTICLES
EDITORIAL POLICY
FOR CONTRIBUTORS
Editorial Office
#301, (Miseung Bldg.) 23, Apgujenog-ro 30-gil, Gangnam-gu, Seoul 06022, Korea
Tel: +82-2-3486-8736    Fax: +82-2-3486-8737    E-mail: registry@ksn.or.kr                

Copyright © 2024 by The Korean Society of Nephrology.

Developed in M2PI

Close layer